Last reviewed · How we verify

NCT06184217

Effects of a Mindfulness Programme on Competitive Athletes With Physical Disabilities

Completed NA Last updated 3 January 2024
What this trial tests

NA trial testing Experimental group (MSPE programme group). in Athletic Injuries in 36 participants. Completed in 17 May 2023.

Timeline
16 November 2022
Primary endpoint
12 April 2023
17 May 2023

Quick facts

Lead sponsorUniversidad Politecnica de Madrid
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment36
Start date16 November 2022
Primary completion12 April 2023
Estimated completion17 May 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad Politecnica de Madrid

Who can join

Adults 15 to 60, any sex, with Athletic Injuries or Physical Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain affects the athlete's sporting career directly or indirectly. Directly, the injury affects other areas of the body causing a physical decompensation in the athlete and this affects the correct execution of the sporting technique, or how technical gestures can cause pain. Indirectly, through the psychological consequences of pain that generate a series of negative consequences and feelings. Some studies suggest that psychological skills are an important tool for pain management. For that reason, a mindfulness intervention programme would be a useful tool for manage pain in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Athletic Injuries

Currently open trials in the same condition.

Other Universidad Politecnica de Madrid trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06184217.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing